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Abstract  
Leishmaniasis represents a complex, globally widespread opportunistic infection ranging from the visceral form, 
also called kala-azar, to the mucocutaneous and cutaneous disease.
 
It is endemic in the Mediterranian Basin, 
Leishmania infantum being demonstrated as the main causative agent of autochthonous cases in Sicily, Italy. The 
long-term use of systemic antipsoriatic agents, including biotechnological drugs, may cause a higher susceptibility 
to opportunistic infections, so physicians maintain a high level of suspicion with treated patients. However, some 
skin tumours, because of the rare occurrence and/or the atypical clinical features, may mimic another kind of 
disease thus leading to a delay in diagnosis and treatment. An exemplary case is reported herein.  
Case report 
 
A 57-year-old Caucasian man, who was a 
farmer affected by psoriasis and treated with 
cyclosporine A periodically in the last two years, 
presented for the first time to our Unit with a one-year 
history of an asymptomatic, approximately round, 
well-demarcated lesion on the second finger of the left 
hand, reported as the possible consequence of a 
previous trauma or insect bite. In anamnesis, the 
patient revealed that indeed he had subsequently 
noticed a small bump, gradually increasing in size and 
elevating, but never experiencing pain in the affected 
area. Apart from psoriasis, medical history was also 
notable for the chronic obstructive pulmonary disease.  
The lesion was initially treated with topical 
gentamycin/betamethasone cream for about one 
month, and then the patient commenced oral 
amoxicillin/clavulanate (2g/day) for two months. 
Because of the lack of any improvement, together with 
the further ulceration of the nodule, and having 
cutaneous leishmaniasis in mind as suspect 
diagnosis, general physician empirically prescribed 
rifampicin (600 mg/day for two months) and then oral 
itraconazole (200 mg/day for one month) with no 
significant changes of the clinical picture. He also 
proposed possible intralesional therapy with 
meglumine antimoniate, but the patient sought 
dermatological consultation. 
Cutaneous examination revealed a firm, flesh-
coloured, slightly erythematous eroded nodule, 
measuring 9 mm in diameter, located on the medial 
surface of the medial phalange, close to the 
interphalangeal joint. The skin surrounding the tumour 
was normal, except for xerosis with light scaling (Fig.1 
and 2). 
An x-ray film of the hand in two projections 
showed no evidence of bone abnormality. A biopsy 
specimen was obtained: hematoxylin-eosin staining 
revealed an ulcerated surface epithelium with 
hyperkeratosis and acanthosis and nests of non-
pigmented atypical epithelioid cells at the dermo-
epidermal junction; also, nests and trabeculae of 
neoplastic cells extended down to the reticular dermis.  
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Figure 1: Ulcerated amelanotic nodule of the second finger, left 
hand 
Frequent mitotic activity was present, with 
poor intra- or perilesional inflammation and no 
vascular involvement (Fig. 3 and 4); 
immunohistochemical staining, revealing strong S-100 
and HMB-45 protein expression (Fig. 5), confirmed 
the diagnosis of amelanotic melanoma. 
 
Figure 2: Particular of the lesion 
 
Surgical excision of the neoplasm was 
requested, and the patient decided to continue the 
diagnostic and therapeutic procedure at another 
centre.  
 
 
Discussion 
Malignant melanoma (MM) is one of the most 
aggressive malignant neoplasms with a steadily 
increasing incidence in the last 30 years as well as 
mortality, despite the advances in treatment [1, 2]. 
When localised at acral body sites, it is much more 
frequent in dark-skinned and Oriental populations [3]. 
Typically, the clinical hallmark of cutaneous MM is the 
presence of pigment, varying from black to blue, to the 
shades of brown, tan, pink and white, within lesions 
with irregular contours on clinical examination [4].  
 
Figure 3: Histological view, H&E stain, original magnification x100 
(detailed in the text) 
 
On the contrary, amelanotic melanoma shows 
little or no pigment on visual inspection. Although the 
incidence of amelanotic melanoma among MM is low 
(2% to 8% of cases), the digits (and the subunguals) 
seem to be an area of predilection, a rate of about 
25% of MM being amelanotic at these sites [5, 6]. In 
dermatologic consultation, the skilled eye of the 
specialized observer as well as dermoscopy, if 
applicable, are the unique instruments to make an 
often difficult diagnosis [7, 8], whereas radiographic 
studies of the part are useful to exclude bone lesions 
[9].  
 
Figure 4: Histological view, H&E stain, original magnification x100 
(detailed in the text) 
In facts, there is still no evidence that 
amelanotic melanomas behave more aggressively 
than their pigmented counterpart, but the lack of 
pigmentation obviously adds further difficulties to an 
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already hard diagnosis. As in all types of MM, there is 
a direct relationship between increasing tumour 
thickness and decreasing survival time. Due to its 
atypical presentation, with consequent late detection, 
amelanotic melanoma is often diagnosed at a late 
stage of the disease with a worsened prognosis [4, 
10].  
 
Figure 5: Immunohistochemical staining (HMB-45) 
 
About our case, the confounding anamnesis 
represented an additional misleading, as the patient 
came from a rural area endemic for cutaneous 
leishmaniasis [11, 12] and the clinical picture of the 
condition was also evocative [13].  
Also, immunosuppression in patients treated 
for the chronic autoimmune disease could 
theoretically facilitate the occurring of opportunistic 
infections [14]. This concern has to be dramatically 
stressed nowadays with the growing use of 
biotechnological drugs [15]. 
In conclusion, we presented the case with the 
aim of underlining the importance for physicians of 
performing incisional biopsies in the presence of 
clinically featureless cutaneous lesions. In particular, 
although asymptomatic, clearly growing amelanotic 
papules and nodules, with no of diagnostic criteria at 
imaging (e.g., Dermoscopy or x-ray) and with 
ulceration, should be histologically evaluated to 
exclude malignant melanoma at a first stage. Local or 
systemic prolonged medical treatments should be 
avoided in the absence of immediate improvement. 
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